Related Experiment Video
Updated: Apr 6, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
New antibiotics against gram-positives: present and future indications
Laura Morata1, Josep Mensa1, Alex Soriano1
1Department of Infectious Diseases, University of Barcelona, IDIBAPS, Spain.
Abstract:
Gram-positive cocci are the most frequent aetiology of community and nosocomially bacterial acquired infections. The prevalence of multidrug-resistant gram-positive bacteria is increasing and is associated with high morbidity and mortality. New antibiotics will be available in the European market during the next months. This revision is focused on lipoglycopeptides, new cephalosporins active against methicillin-resistant Staphylococcus aureus (MRSA) and the new oxazolidinone, tedizolid. The purpose of this review is to describe their in vitro activity, pharmacokinetic and pharmacodynamic characteristics, and experience from clinical trials.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bacterial Cell Wall
Inhibitors of Bacterial DNA Synthesis

